NVE
NVEC on Nasdaq. NVE Corp /new/ sells magnetic sensors and couplers to makers of electronic systems. Market value $393m.
Price checks use the past 12 months to September 2026. Quality checks use five annual reports, the latest for the year to March 2026.
Should I look at this?
Worth a closer look
Why it could be worth it
What to watch out for
Nothing big in our quick check. See what could go wrong below.
This is not advice. Check the numbers below.
For every $100 of what the whole company costs, it produced $5.50 of spare cash in the past 12 months. A savings account pays about $4.
You pay 17.7 years of operating profit for the business. The average large US company costs around 18.
Each dollar kept in the business earns 24 cents a year. Above 10 is good.
Quality score: 97 of 100. Price score: 82 of 100. Our list needs 70 on quality and 60 on price.
$70.04 a share, 22% above its 1-year low
Over the past year the price has ranged from $57.22 to $135.00.
Dividend: 5.7% a year
Paid every year for at least 5 years
Prices from Friday’s close (20 November).
Five years of cash, in billions
| Revenue | |||||
| Revenue | $27m | $38m | $30m | $26m | $26m |
| Operating margin | |||||
| Operating margin | 60.5% | 67.0% | 62.1% | 61.8% | 60.5% |
| Debt to equity | |||||
| Debt to equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Shares outstanding | |||||
| Shares outstanding | 0.00bn | 0.00bn | 0.00bn | 0.00bn | 0.00bn |
Health checks
- Free cash flow positive5 of 5 years
- Accounting looks honest (Beneish)Not enough data
- Financial strength (Piotroski)6 of 9
- Profit backed by cash (accruals)Yes
- Debt0.00× equity
- Revenue growth, five yearsSlow, 4.3% a year
- Buying back its own sharesRoughly flat
The quarter to September 2026
How the business did, compared with the same quarter a year earlier.
- Sales: $6 million last quarter, about the same as a year ago.
- Profit: $3 million, about the same as a year ago.
- It keeps 62 cents of each $1 of sales as operating profit, up from 59 cents a year earlier.
- Spare cash over the past 12 months: $19 million, up from $13 million.
- About the same number of shares as a year ago.
- It has $4 million more cash than debt, down from $5 million a year ago.
- Sales grew on a year ago in 3 of the last 4 quarters.
| Quarter to | Amount |
|---|---|
| December 2024 | $5m |
| March 2025 | $7m |
| June 2025 | $6m |
| September 2025 | $6m |
| December 2025 | $6m |
| March 2026 | $8m |
| June 2026 | $11m |
| September 2026 | $6m |
| Quarter to | Amount |
|---|---|
| December 2024 | $3m |
| March 2025 | $4m |
| June 2025 | $4m |
| September 2025 | $3m |
| December 2025 | $3m |
| March 2026 | $5m |
| June 2026 | $6m |
| September 2026 | $3m |
From the company's quarterly reports to the SEC.
Dates
- Next results (estimated)
- n/a
- Last annual report (10-K)
- 6 May 2026
- Next quarterly (estimated, 10-Q)
- 20 January 2027
Who owns it
3 long-term investors we follow own it, up from 2 last quarter. 134 funds in all.
- Mairs & PowerAndy Adams
- Value
- $627,300
- Share of fund
- <0.1%
| Fund | Value | Share of that fund | Change |
|---|---|---|---|
| Royce & AssociatesChuck Royce | $8m | <0.1% | Cut |
| Mairs & PowerAndy Adams | $627,300 | <0.1% | |
| Barrow HanleyBarrow Hanley team | $6,168 | <0.1% | New |
Largest holders overall
- Defiance ETFs$67mAdded
- Penserra Capital Management$66mAdded
- BlackRock$44mAdded
- State Street$39mAdded
- Vanguard Capital Management$23mAdded
- Vanguard Portfolio Management$20mAdded
- Renaissance Technologies$18m
- Geode Capital Management$16mAdded
- Ranger Investment Management, L.P.$13m
- Dimensional Fund Advisors LP$11mAdded
From 13F filings for the quarter ended 30 June 2026.
Big holders and activists
2 investors own more than 5%.
- STATE STREET CORPORATIONPassive investorat least 7.8%(filed with 1 related holder)Since 30 June 2026
- Vanguard Capital ManagementPassive investor5.0%Since 31 March 2026
- Royce & AssociatesPassive investorSold down below 5%Since 31 March 2026
- Kayne Anderson Rudnick Investment Management, LLCPassive investorSold down below 5%Since 30 September 2025
- Virtus Investment Advisers, LLCPassive investorSold down below 5%Since 30 June 2025
- The Vanguard GroupPassive investorSold down below 5%Since 13 March 2026
| Holder | Stake | Since | |
|---|---|---|---|
STATE STREET CORPORATION Passive investor | at least 7.8% (filed with 1 related holder) | 30 June 2026 | |
Vanguard Capital Management Passive investor | 5.0% | 31 March 2026 | |
Royce & Associates Passive investor | Sold down below 5% | 31 March 2026 | |
Kayne Anderson Rudnick Investment Management, LLC Passive investor | Sold down below 5% | 30 September 2025 | |
Virtus Investment Advisers, LLC Passive investor | Sold down below 5% | 30 June 2025 | |
The Vanguard Group Passive investor | Sold down below 5% | 13 March 2026 |
From Schedule 13D and 13G filings: anyone owning more than 5% must file one.
What insiders did
No insider bought shares on the open market in the last 12 months. 1 sold $5m.
- BAKER DANIEL ADirectorSold
- Date
- 8 September 2026
- Shares
- 21,140
- Price
- $101.49
- Value
- $2m
- BAKER DANIEL ADirectorSold
- Date
- 27 August 2026
- Shares
- 4,000
- Price
- $109.50
- Value
- $438,000
- BAKER DANIEL ADirectorSold
- Date
- 25 August 2026
- Shares
- 1,731
- Price
- $107.00
- Value
- $185,217
- BAKER DANIEL ADirectorSold
- Date
- 17 August 2026
- Shares
- 1,500
- Price
- $121.50
- Value
- $182,250
- BAKER DANIEL APresident & CEO, DirectorSold
- Date
- 29 July 2026
- Shares
- 15,222
- Price
- $114.08
- Value
- $2m
- BAKER DANIEL APresident & CEO, DirectorSold
- Date
- 28 July 2026
- Shares
- 3,260
- Price
- $117.57
- Value
- $383,278
- BAKER DANIEL APresident & CEO, DirectorSold
- Date
- 27 July 2026
- Shares
- 1,518
- Price
- $117.56
- Value
- $178,456
- BAKER DANIEL APresident & CEO, DirectorSold
- Date
- 29 January 2026
- Shares
- 103
- Price
- $72.25
- Value
- $7,442
- BAKER DANIEL APresident & CEO, DirectorSold
- Date
- 27 January 2026
- Shares
- 1,155
- Price
- $74.04
- Value
- $85,516
| Date | Who | Did | Shares | Price | Value |
|---|---|---|---|---|---|
| 8 September 2026 | BAKER DANIEL A Director | Sold | 21,140 | $101.49 | $2m |
| 27 August 2026 | BAKER DANIEL A Director | Sold | 4,000 | $109.50 | $438,000 |
| 25 August 2026 | BAKER DANIEL A Director | Sold | 1,731 | $107.00 | $185,217 |
| 17 August 2026 | BAKER DANIEL A Director | Sold | 1,500 | $121.50 | $182,250 |
| 29 July 2026 | BAKER DANIEL A President & CEO, Director | Sold | 15,222 | $114.08 | $2m |
| 28 July 2026 | BAKER DANIEL A President & CEO, Director | Sold | 3,260 | $117.57 | $383,278 |
| 27 July 2026 | BAKER DANIEL A President & CEO, Director | Sold | 1,518 | $117.56 | $178,456 |
| 29 January 2026 | BAKER DANIEL A President & CEO, Director | Sold | 103 | $72.25 | $7,442 |
| 27 January 2026 | BAKER DANIEL A President & CEO, Director | Sold | 1,155 | $74.04 | $85,516 |
From Form 4 filings: insiders must report trades in their own company's shares within two days.
How the boss is paid
Daniel A. Baker was paid $585,775 in 2026.
The yearly bonus pays for per-share results:
We couldn’t tell from the filing.
The long-term stock award pays for per-share results:
We couldn’t tell from the filing.
Why it matters: new shares can grow total profit while each share earns less. Per-share goals pay the boss only when your slice grows.
From the proxy statement (the company’s yearly voting pack) filed 22 June 2026. Picked out automatically from the company’s own filing. Evidence, not our verdict.
Warning signs in its filings
Problems the company itself reported to the SEC, in its own words.
We couldn’t fully check NVE’s latest annual report.
We look for five warning signs: doubt it can keep going, weak checks on its own accounts, a notice that its past accounts can't be relied on, a change of auditor, and one customer bringing in a big share of sales. We don't check lawsuits, investigations or debt yet.
We couldn't fully read the 10-K filed 6 May 2026, so we can't say there are no warning signs.
One big customer
Worth knowingOne customer brings in a big share of sales: 37% last year. Losing that customer would hurt.
“Customer A | 37% | 35% | 27% | 26%”
From the 10-K filed 6 May 2026, Item 15. Exhibits and Financial Statements (table). Read it in the filing
A 10-K is the yearly report every US company files with the SEC. An 8-K is a short notice of a big event.
What could go wrong
Cheap for a reason is the question the numbers cannot answer.
Whether the price already reflects the risks is what the deep dive is for.
What changed in the risks this year
Companies must list what could hurt them each year. These are the parts that changed since last year’s report.
Changes in state regulatory requirements may materially and adversely affect our financial condition, results of operations, and cash flows.
Already happenedMinnesota state legislation effective January 1, 2026 mandated paid family and medical leave, which has increased our employment costs and expenses. The provisions may also increase our risk of employee absences. Future changes in state regulatory requirements, such as paid leave, mandatory healthcare coverage, or unemployment insurance, may adversely impact our financial results.
Read moreOur business could be negatively impacted by cybersecurity events or information technology disruptions.
Could happenAccounting standards require us to measure our allowance for credit losses based on the expected credit losses over the life of our receivables. Any increases in our allowance for credit losses would have a negative impact on our financial results, including reducing our net income and net income per share.
Read moreChanges in tax law, in our tax rates, or in exposure to additional income tax liabilities may materially and adversely affect our financial condition, results of operations, and cash flows.
Could happenChanges in law and policy relating to Federal or state corporate taxes, changes in tax rates, or changes in our eligibility for tax deductions and credits could materially and adversely affect our financial condition, results of operations, and cash flows.
Some of our products are incorporated into medical devices, which could expose us to a risk of product liability claims and such claims could seriously harm our business and financial condition.
Could happenCertain of our products are used in medical devices, including devices that help sustain human life. Although we have indemnification agreements with certain customers including provisions designed to limit our exposure to product liability claims, there can be no assurance that we will not be subject to losses, claims, damages, liabilities, or expenses resulting from bodily injury or property damage arising from the incorporation of our products in devices sold by our customers. Our indemnifying customers may not have the financial resources to cover all liability. Existing or future laws or unfavorable judicial decisions could limit or invalidate the provisions of our indemnification agreements, or the agreements may not be enforceable in all instances. A successful product liability claim could require us to pay, or contribute to payment of, substantial damage awards, which would have a significant negative effect on our business and financial condition.
Read more
The deep dive
Everything above is arithmetic on public filings. The deep dive reads the last ten years of annual reports, the proxy statements, and the earnings calls, then argues the case the way Buffett, Klarman, and Hohn would, and checks every claim against the source.
- What the business is worth, as a range, and the margin of safety at today’s price
- Prices to start buying, buy, and buy hard
- The three things that would make this a mistake
- Every number footnoted to the filing it came from
The company just reported its latest figures. The deep dive shows what they mean for the price you pay.
Your first deep dive is free.
Not advice. Numbers on this page come from SEC filings and are updated each night; prices are updated again after the US market closes. The five-year figures are rounded.